Durata Therapeutics Inc., an affiliate of Allergan
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Durata Therapeutics Inc., an affiliate of Allergan sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Durata Therapeutics Inc., an affiliate of Allergan: 4 sponsored US clinical trials, none currently recruiting.
Durata Therapeutics Inc., an affiliate of Allergan sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cellulitis, with 1 trials.
Upper-quartile sponsor footprint
Durata Therapeutics Inc., an affiliate of Allergan sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT02127970
A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
NCT01946568
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT01431339
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT01339091
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 3 |
Therapeutic Areas
How the Durata Therapeutics Inc., an affiliate of Allergan archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Cellulitis (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Durata Therapeutics Inc., an affiliate of Allergan: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Durata Therapeutics Inc., an affiliate of Allergan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Durata Therapeutics Inc., an affiliate of Allergan page
4 registered trials is a research-attention snapshot, not an endorsement of Durata Therapeutics Inc., an affiliate of Allergan or any single study.
- None of Durata Therapeutics Inc., an affiliate of Allergan's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cellulitis is the condition Durata Therapeutics Inc., an affiliate of Allergan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cellulitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Durata Therapeutics Inc., an affiliate of Allergan pipeline card: 4 registered trials from official public datasets.Report a data error.